Additionally, phosphoproteomic analysis identified 34,977 phosphosites corresponding to 6,864 phosphoproteins in tumor samples (n = 17) and 27,251 phosphosites corresponding to 5,896 phosphoproteins in NAT samples (n = 16). This evidence concerns the gene BRD2 and neoplasm.